Apheresis Units, Therapeutic, Low-Density Cholesterol

Definition : Therapeutic apheresis units designed to remove low-density lipoprotein (LDL) cholesterol from the blood. Typically, the unit includes a specialized filter that eliminates the LDL (including the very low-density [VLD]) cholesterol particles from the blood and two intravenous lines; one line is used to draw blood from one arm and the other to return the blood into the other arm after LDL cholesterol filtration. LDL cholesterol removal apheresis units are used periodically (e.g., every other week) when diet, exercise, and drugs do not provide an adequate treatment for high levels of cholesterol. Other blood products such as triglycerides and fibrinogen are also lowered with this apheresis treatment.

Entry Terms : "Triglyceride Apheresis Units" , "Apheresis Units, Therapeutic, Liposorption" , "Low-Density Cholesterol (LDL) Absorption Apheresis Units"

UMDC code : 23139

U.S.companies only
Suppress Subsidiary Companies

1-1 of 1 Match(es).

Haemonetics Corp

Company Type: Parent

Haemonetics founder Jack Latham had a vision to bring together a commitment to quality and customer service with innovation in building a company to produce blood fractionation devices.Our comprehensive portfolio of devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain — from plasma and blood collectors to hospitals.

1-1 of 1 Match(es).


Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs
Medical Product Guide Cancer Therapy Advisor Product Zone